Miyazaki et al. reported that high dose intravenous injection or overexpression of Musclin in the liver of transgenic mice improved survival and attenuated cardiac hypertrophy, but did not improve heart function following myocardial infarction, mainly by reducing myocardial inflammation and infarct size17. Here, OSTN is linked to myocardial infarction.